𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Influence of Chelating Groups on the Luminescence Properties of Europium(III) and Terbium(III) chelates in the 2,2′-bipyridine series

✍ Scribed by Veli-Matti Mukkala; Marek Kwiatkowski; Jouko Kankare; Harri Takalo


Publisher
John Wiley and Sons
Year
1993
Tongue
German
Weight
445 KB
Volume
76
Category
Article
ISSN
0018-019X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Eight different 2,2′‐bipyridine derivatives, i.e. 2, 5, 8, 10, 12, 13, 15, and 19 (Schemes 1 and 2), were prepared to study the influence of the chelating groups on the luminescence properties of their Eu^III^ and Tb^III^ chelates. According to our luminescence results, 2,2′‐(methylenenitrilo)bis(acetic acid) as well as (methylenenitrilo)bis‐(methylphosphonic acid) in 6‐ and 6′‐position of 2,2′‐bipyridine is a suitable group when developing luminescent markers for bioaffinity assays based on time‐resolved luminescence measurement.


📜 SIMILAR VOLUMES


Comparative Study of the Luminescence Pr
✍ David Parker; James W. Walton; Laurent Lamarque; Jurriaan M. Zwier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

## Abstract The synthesis and spectral properties are reported of a set of four europium(III) complexes containing between one and four 3‐azaxanthone sensitising chromophores. Each complex is based on a macrocyclic cyclen core. The emission and aqueous solution ^1^H NMR spectral properties are comp

Standard molar enthalpies of formation o
✍ Edward Giera 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 180 KB

The standard ( p o = 0.1 MPa) molar enthalpies of formation of lanthanum(III), praseodymium(III), neodymium(III), samarium(III), gadolinium(III), dysprosium(III), holmium(III) and erbium(III) crystalline chelate complexes with 2,2,6,6-tetramethyl-3,5heptanedione (dipivaloylmethane, HDPM) at the temp

Efficacy and safety of the PPARγ partial
✍ Kim Henriksen; Inger Byrjalsen; Per Qvist; Henning Beck-Nielsen; Gitte Hansen; B 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 1 views

## Abstract ## Background Treatment of patients with perioxisome proliferator‐activated receptor‐γ full agonists are associated with weight gain, heart failure, peripheral oedema, and bone loss. However, the safety of partial perioxisome proliferator‐activated receptor‐γ agonists has not been esta